The deal, if and when concluded, will also involve the purchase of the diagnostics arm SRL, these people said.

The Baba Ramdev-led company clocked revenue of Rs 10,561 crore in FY17, making it the second-largest pure-play FMCG player after market lea...

The Budget’s focus on youth, rural economy, agriculture, affordable housing, cleanliness and digitisation augur well for building the long ...

Convinced that new consumers can be found in heaps in the mosaic that is the Indian market, Mehta is giving his managers a new structure to...

For most Indian companies, growth slowed down to 15 to 20%. Aided by a record-low rupee, most companies gained from realisations from the U...

The deferral of implementation of the amendments related to pack-size regulation from July 1 to November 1 2012 may seem to be no-event.

ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.

Stock traders, who were gearing up for a subdued close on Friday, were caught by surprise in the last hour of trading after benchmark indic...

Exporters are worried that the debt crisis in the western world will hit demand and lead to a payments problem.

Pfizer India, the Indian arm of the US drug major Pfizer Inc, reported muted performance for the four months ended March 2011.

Cigarettes-to-hotels conglomerate ITC’s June quarter results were a watershed event for the company’s agri-commodities businesses.

Cigarettes-to-hotels conglomerate ITC’s June quarter results were a watershed event for the company’s agri-commodities businesses.

TCS reported a forex loss of Rs 251 crore for the December quarter & Ranbaxy has reported a record forex loss of Rs 953 crore for the quart...

Rural consumers are displaying considerable resilience in spends on fast-moving consumer goods (FMCG) despite the economic slowdown, say to...

Few people outside the pharma industry are likely to be aware that Sun Pharmaceutical and not Ranbaxy, Cipla or Dr Reddy’s is India’s most ...

The FMCG major is all set to realign managerial structure in line with parent Unilever’s global strategy that may put some jobs on the line...

Sun Pharmaceuticals registered a spectacular performance during the December 2007 quarter